Top 4 Canadian Biotech Stocks (Updated January 2025)

1 day ago · Data on Canadian biotech stocks was collected on January 14, 2025, using TradingView's stock screener. Only companies with market capitalizations of over C$50 million at that time were considered.

$50
OFF

Top 4 Canadian Biotech Stocks (Updated January 2025)

2 weeks from now

nasdaq.com

$0
OFF

10 Best Canadian Biotech Stocks (Jan 2025) - Wealth Awesome

2 weeks from now

Ticker: BLU.TOSize: Small-capForward Dividend Yield:N/AMarket Cap:$0

wealthawesome.com

3%
OFF

5 Biotech Stocks Worth Adding To Your Portfolio In 2025

2 weeks from now

2 days ago · The Zacks Consensus Estimate for 2024 EPS has increased 15 cents to $4.13 and 23 cents to $4.99 for 2025 in the past 90 days. Shares of the company have surged 57.3% in …

zacks.com

45%
OFF

7 Best Biotech ETFs In Canada For January 2025 - Wealth Awesome

2 weeks from now

Sep 13, 2024 · Ticker: NASDAQ:IBB Inception Date: February 05, 2001 Assets Under Management: US$6.98 billion Management Fee: 0.45% Yield: 0.27%; Stock Price: $146.88 …

wealthawesome.com

$50
OFF

Top 5 Small-cap Biotech Stocks (Updated January 2025)

2 weeks from now

Jan 7, 2025 · Data was gathered on January 7, 2025, using TradingView’s stock screener, and all top small-cap biotech stocks in the list had market caps between US$50 million and US$500 …

nasdaq.com

$42.64
OFF

5 Biotech Stocks On The TSX | INN - Investing News Network

2 weeks from now

Aug 30, 2017 · Aptose Biosciences (TSX:APS) Market cap: $42.64 million; current share price: $1.78 Aptose is a biotech working on treatments for some of the most serious diseases like …

investingnews.com

$1.55
OFF

Top 4 Canadian Biotech Stocks Of 2024 – Right Investing Way

2 weeks from now

Nov 1, 2024 · According to Grandview Research, the global biotech market was worth US$1.55 trillion in 2023, and the firm expects it to grow at a CAGR of 13.96 percent between 2024 and …

rightinvestingway.com

FAQs about Top 4 Canadian Biotech Stocks (Updated January 2025) Coupon?

Are biotech stocks a good investment in Canada?

In the last two decades, an exciting biotech market has emerged on the Toronto Stock Exchange (TSX). While most of these stocks are still small caps, many have the innovation and research to grow into larger businesses. If you’re interested in biotechnology stocks in Canada, here are three top companies you should consider. ...

What are biotech stocks?

1. Research and discovery 2. Preclinical testing 3. Clinical testing 4. Regulatory approval 1. BELLUS Health 2. Theratechnologies 3. BriaCell Therapeutics 4. Medicenna Therapeutics Corp. Are biotech stocks right for you? Biotech stocks are companies that use living organisms to make drugs and vaccines. ...

Is ceapro a good Biotech stock in Canada?

Ceapro is different from all the other best Canadian biotech stocks on this list because of its diversified focus, which includes applications (for the biological agents it’s developing) other than healthcare. ...

Are biotech ETFs listed on Canadian stock exchanges?

Being the country where ETFs originated, it is surprising that there are no biotech ETFs listed on Canadian stock exchanges. Fortunately, if you are a Canadian investor interested in gaining diversified exposure to the biotech industry, you can still invest in biotech ETFs listed in international stock markets. 1. ...

What is the global biotech market worth in 2023?

According to Grandview Research, the global biotech market was worth US$1.55 trillion in 2023, and the firm expects it to grow at a CAGR of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion. The Investing News Network profiles the four best-performing Canadian biotech stocks based on their year-on-year gains below. ...

How big is the biotech industry in Canada?

In Canada, the biotech industry is home to companies pursuing cutting-edge therapies and medical technologies. According to Grandview Research, the global biotech market was worth US$1.55 trillion in 2023, and the firm expects it to grow at a CAGR of 13.96 percent between 2024 and 2030 to reach a value of US$3.08 trillion. ...